Patents by Inventor Kelly-Anne PIKE

Kelly-Anne PIKE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Enhancing CD8+ T cells for adoptive T cell therapy by inhibiting PTPN1 (PTP1B) and PTPN2 (TC-PTP)
    Patent number: 11597739
    Abstract: The invention encompasses ex vivo method of stimulating isolated memory T-cell, tumor-infiltrating lymphocyte (TIL), T cell receptor (TCR) engineered cell, and/or chimeric antigen receptor (CAR) engineered cell with compounds of Formula I below, which are inhibitors of the TC-PTP enzyme.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: March 7, 2023
    Assignee: THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY
    Inventors: Michel L. Tremblay, Kelly-Anne Pike, Luis Alberto Perez Quintero
  • ENHANCING CD8+ T CELLS FOR ADOPTIVE T CELL THERAPY BY INHIBITING PTPN1 (PTP1B) AND PTPN2 (TC-PTP)
    Publication number: 20210155645
    Abstract: The invention encompasses ex vivo method of stimulating isolated memory T-cell, tumor-infiltrating lymphocyte (TIL), T cell receptor (TCR) engineered cell, and/or chimeric antigen receptor (CAR) engineered cell with compounds of Formula I below, which are inhibitors of the TC-PTP enzyme.
    Type: Application
    Filed: August 24, 2018
    Publication date: May 27, 2021
    Inventors: Michel L. TREMBLAY, Kelly-Anne PIKE, Luis Alberto PEREZ QUINTERO